TIMP3 and non-small cell lung carcinoma: miR-221 and miR-222 modulate the resistance to TRAIL and promote tumorigenesis via downregulating PTEN and TIMP3 in both aggressive non-small-cell lung cancer and hepatocarcinomatous cells (22).